Image: Pathology: SEM: Cancer Cells: Death. 1st in 6-step sequence death of a cancer cell.
Micrographer: Susan Arnold Source: Dr. Raowf Guirguis. Courtesy, National Cancer Institute
MIT's LABORATORY of NANOMEDICINE OFFERS POSTDOC POSITIONS INMOLECULAR & CELL BIOLOGY; APPOINTMENTS TO COMMENCE MID-2010.
The Sengupta Laboratory is a partner in the Indo-US Joint Center for Nanobiotechnology
and is affiliated with the BWH-HST Center for Biomedical Engineering,Department of Medicine at the Brigham and Women's Hospital, Harvard
Medical School and MIT. This allows access to research resources and
collaborators within Harvard University, Harvard Medical School and
Affiliated Teaching Hospital, as well as MIT.
The initiative is supported by the Indo-US Science and Technology Forum and the Department of Science and Technology, Government of India. It
brings together leaders in nanotechnology and biology from USA (Harvard
and MIT) and India (NCBS, JNCASR, and CCMB).
Postdoctoral fellows with strong research records are encouraged tosubmit.
Postdoctoral candidates should apply directly to the PI.
PhD students are accepted from theHST-MEMP or MD/PhD program.
Candidates with outstanding records areinvited to apply. To apply, send a CV and a 2-page research statement
describing research interests and unique suitability:
Undergrads may gain entry via MIT's UROP (Undergraduate ResearchOpportunities Program):
Direct and materials funding:
Shiladitya Sengupta wins $6.96M DoD Collaborative Innovator Award with Erkki Ruoslahti and Roger Tsien: